HHCP
PFE icon

Hilton Head Capital Partners’s Pfizer PFE Stock Holding History

Hilton Head Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Sell
12,900
-397
-3% -$10.4K 0.16% 126
2026
Q1 		$373K Sell
13,297
-234
-2% -$6.23K 0.21% 109
2025
Q4 		$337K Buy
+13,531
New +$341K 0.2% 109

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hilton Head Capital Partners's PFE Position: Q2 2026 in Review

Hilton Head Capital Partners reduced its Pfizer (PFE) stake by 3% in Q2 2026, selling an estimated $10.4K and leaving 12,900 shares worth $311K. The position accounts for 0.16% of the portfolio, ranked #126.

Hilton Head Capital Partners first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $373K in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hilton Head Capital Partners held 12,900 shares of Pfizer worth $311K as of Q2 2026.
  • Hilton Head Capital Partners sold 397 Pfizer shares in Q2 2026, an estimated $10.4K.
  • Pfizer made up 0.16% of Hilton Head Capital Partners's portfolio in Q2 2026, its #126 holding.
  • Hilton Head Capital Partners first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Hilton Head Capital Partners's Pfizer position peaked at $373K in Q1 2026.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hilton Head Capital Partners's 13F filing for Q2 2026, filed 27 Jul 2026.